Abbott: Coronary Artery Disease trials

The registry lists 84 Coronary Artery Disease studies with Abbott as lead sponsor. 0 are open to participants now and 53 have results posted.

Phase 1 1Phase 2 2Phase 3 11Phase 4 10No phase 61(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• XIENCE Skypoint Large Vessel Post Approval StudyActive, not recruitingNCT05423379Results posted
• FUnctional diagnoSIs of corONary Stenosis (FUSION)CompletedNCT04356027Results posted
• Abbott Next Generation Drug Eluting Stent 48mm StudyCompletedNCT04282148Not applicableResults posted
• XIENCE 28 USA StudyCompletedNCT03815175Not applicableResults posted
• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)CompletedNCT03507777Not applicableResults posted
• Absorb GT1 Japan PMSCompletedNCT03409731Not applicableResults posted
• XIENCE 28 Global StudyCompletedNCT03355742Not applicableResults posted
• PRESSUREwire StudyCompletedNCT02935088Results posted
• XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)CompletedNCT02513732Results posted
• XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)CompletedNCT02513719Results posted
• OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent ImplantationCompletedNCT02471586Not applicableResults posted
• SHIELD II Clinical InvestigationTerminatedNCT02468778Not applicableResults posted
• Coronary Flow Reserve Following Orbital AtherectomyCompletedNCT02339545Results posted
• Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery LesionsCompletedNCT02229864Not applicableResults posted
• Absorb IV Randomized Controlled TrialCompletedNCT02173379Not applicableResults posted
• Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)CompletedNCT01930214Results posted
• A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)CompletedNCT01923740Not applicableResults posted
• XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm StudyCompletedNCT01894152Results posted
• AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese PopulationCompletedNCT01844284Not applicableResults posted
• ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.CompletedNCT01759290Results posted
• ABSORB III Randomized Controlled Trial (RCT)CompletedNCT01751906Not applicableResults posted
• XIENCE PRIME Japan Post-Marketing Surveillance (PMS)CompletedNCT01721096Results posted
• A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular ArrhythmiasCompletedNCT01685047Results posted
• Observational Study of OCT in a Patients Undergoing FFRCompletedNCT01663896Results posted
• EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total OcclusionsCompletedNCT01435031Not applicableResults posted
• ABSORB II Randomized Controlled TrialCompletedNCT01425281Not applicableResults posted
• ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator PatientsTerminatedNCT01424722Not applicableResults posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyCompletedNCT01249027Results posted
• EXCEL Clinical TrialCompletedNCT01205776Not applicableResults posted
• A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic LesionsCompletedNCT01186198Results posted
• XIENCE V: SPIRIT WOMEN Sub-studyCompletedNCT01182428Phase 4Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Phase 4Results posted
• SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)CompletedNCT01171820Phase 4Results posted
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMTCompletedNCT01132495Not applicableResults posted
• XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)CompletedNCT01120379Results posted
• A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese PopulationCompletedNCT01115933Not applicableResults posted
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) CohortCompletedNCT01106534Phase 4Results posted
• Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary LesionsCompletedNCT01092416Not applicableResults posted
• XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanCompletedNCT01086228Results posted
• ABSORB EXTEND Clinical InvestigationCompletedNCT01023789Not applicableResults posted
• SPIRIT PRIME Clinical TrialCompletedNCT00916370Phase 3Results posted
• ABSORB Clinical Investigation, Cohort BCompletedNCT00856856Not applicableResults posted
• SPIRIT Small Vessel RegistryTerminatedNCT00783796Not applicableResults posted
• XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)CompletedNCT00676520Results posted
• Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00639158Phase 3Results posted
• EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNCT00531011Phase 4Results posted
• DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging EvaluationTerminatedNCT00487279Not applicableResults posted
• SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00307047Phase 3Results posted
• Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300482Phase 3Results posted
• Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300469Phase 3Results posted
• Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300456Phase 3Results posted
• Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.CompletedNCT00300430Phase 3Results posted
• SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)CompletedNCT00180479Phase 3Results posted
• TECTONIC CAD IVL IDE StudyActive, not recruitingNCT06885177Not applicable
• Patient Centered Machine Learning Model for Bleeding and Ischemic RiskCompletedNCT06089304
• CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human StudyWithdrawnNCT05695716Not applicable
• Cardiovascular Systems Inc. (CSI) pVAD First in Human StudyCompletedNCT05315544Not applicable
• Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE TrialActive, not recruitingNCT03108456Not applicable
• ABSORB Post-Approval Clinical StudyWithdrawnNCT02943616Not applicable
• Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) ImplantCompletedNCT01993862Not applicable
• To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated VesselsCompletedNCT01977534
• EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNCT01310309
• ABSORB PHYSIOLOGY Clinical InvestigationTerminatedNCT01308346Not applicable
• EXCEL Clinical Trial (Universal Registry)CompletedNCT01205789
• Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in FranceCompletedNCT00987506
• AnalyST Treadmill StudyCompletedNCT00949000Not applicable
• Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) TherapyCompletedNCT00919373Not applicable
• Angio-Seal Evolution Device RegistryCompletedNCT00817349
• A(f)MAZE-CABG StudyTerminatedNCT00735722Not applicable
• XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in DeliveryCompletedNCT00731237
• XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm StudyCompletedNCT00631228
• The TRIMAXX Coronary Stent TrialCompletedNCT00596661Phase 1
• XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4
• SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in EuropeCompletedNCT00402272Phase 4
• The Ischemia Modified Albumin In Diagnosing Ischemic New EventsTerminatedNCT00355992
• ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical InvestigationCompletedNCT00300131
• Frontier Registry II Bifurcation Stent System RegistryWithdrawnNCT00286195Phase 4
• Vision II: Evaluation of GALILEO Intravascular Radiotherapy SystemCompletedNCT00180583Phase 4
• PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic LesionsCompletedNCT00180466
• SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180453Phase 3
• SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180310Phase 3
• Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary ArteriesCompletedNCT00148356Phase 2/3
• Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary ArteriesCompletedNCT00140101Phase 2
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELLCompletedNCT00079638Phase 4